Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer

被引：0
|
作者：
Haruhiko Yamazaki
Tomoyuki Yokose
Hiroyuki Hayashi
Hiroyuki Iwasaki
Sachie Osanai
Nobuyasu Suganuma
Hirotaka Nakayama
Katsuhiko Masudo
Yasushi Rino
Munetaka Masuda
机构：
[1] Kanagawa Cancer Center,Department of Breast and Endocrine Surgery
[2] Kanagawa Cancer Center,Department of Pathology
[3] Yokohama City University Medical Center,Department of Breast and Thyroid Surgery
[4] Yokohama City University School of Medicine,Department of Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 82卷
关键词：
Thyroid cancer; Molecular biology; Clinical research; Lenvatinib; Vascular endothelial growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 654
页数：5
相关论文
共 50 条
  • [1] Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer
    Yamazaki, Haruhiko
    Yokose, Tomoyuki
    Hayashi, Hiroyuki
    Iwasaki, Hiroyuki
    Osanai, Sachie
    Suganuma, Nobuyasu
    Nakayama, Hirotaka
    Masudo, Katsuhiko
    Rino, Yasushi
    Masuda, Munetaka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 649 - 654
  • [2] Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study
    Yamazaki, Haruhiko
    Yokose, Tomoyuki
    Hayashi, Hiroyuki
    Iwasaki, Hiroyuki
    Osanai, Sachie
    Suganuma, Nobuyasu
    Nakayama, Hirotaka
    Masudo, Katsuhiko
    Rino, Yasushi
    Masuda, Munetaka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (05) : 703 - 709
  • [3] Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study
    Haruhiko Yamazaki
    Tomoyuki Yokose
    Hiroyuki Hayashi
    Hiroyuki Iwasaki
    Sachie Osanai
    Nobuyasu Suganuma
    Hirotaka Nakayama
    Katsuhiko Masudo
    Yasushi Rino
    Munetaka Masuda
    European Journal of Clinical Pharmacology, 2020, 76 : 703 - 709
  • [4] Expression of Estrogen Receptor, Progesterone Receptor, and Vascular Endothelial Growth Factor-A in Thyroid Cancer
    Kansakar, Erina
    Chang, Yeon-Jeen
    Mehrabi, Massoud
    Mittal, Vijay
    AMERICAN SURGEON, 2009, 75 (09) : 785 - 789
  • [5] Expression of Estrogen Receptor, Progesterone Receptor, and Vascular Endothelial Growth Factor-A in Thyroid Cancer DISCUSSION
    Ranks, John B.
    Feliciano, David
    Kansakar, Erina
    AMERICAN SURGEON, 2009, 75 (09) : 789 - 789
  • [6] Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer
    Xia, GB
    Kumar, SR
    Hawes, D
    Cai, J
    Hassanieh, L
    Groshen, S
    Zhu, ST
    Masood, R
    Quinn, DI
    Broek, D
    Stein, JP
    Gill, PS
    JOURNAL OF UROLOGY, 2006, 175 (04): : 1245 - 1252
  • [7] Vascular Endothelial Growth Factor A and its receptor Vascular Endothelial Growth Factor Receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
    Skov, Guldhammer Birgit
    Bonnesen, Barbara
    Holmstav, Julie G.
    Pappot, Helle
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S881 - S881
  • [8] Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
    Bonnesen, Barbara
    Pappot, Helle
    Holmstav, Julie
    Skov, Birgit Guldhammer
    LUNG CANCER, 2009, 66 (03) : 314 - 318
  • [9] Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung
    Janvier, A
    Nadeau, S
    Baribeau, J
    Perreault, T
    CRITICAL CARE MEDICINE, 2005, 33 (04) : 860 - 866
  • [10] Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer
    Rydén, L
    Jirström, K
    Bendahl, PA
    Fernö, M
    Nordenskjöld, B
    Stål, O
    Thorstenson, S
    Jönsson, PE
    Landberg, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4695 - 4704
12345